Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.47 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.47 |
| ▸ | CSNK2A3 | Q8NEV1 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | USP8 | P40818 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22822367 | 0.86 | KDM4E (0.51) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801034 | 0.84 | KDM4E (0.50) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801115 | 0.83 | KDM4E (0.46) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801090 | 0.78 | CSNK2A2 (0.54) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801025 | 0.77 | KDM4E (0.56) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801038 | 0.77 | KMT2A (0.49) | KDM4EMAPTRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL22801111 | 0.76 | KDM4E (0.53) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801107 | 0.76 | SLC2A1 (0.48) | KDM4EMAPTCSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL22801082 | 0.76 | MAPT (0.49) | KDM4EMAPTRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL31197884 | 0.75 | KCNQ1 (0.43) | KDM4EMAPTRAB9ANPC1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | NATIONAL INSTITUTES OF HEALTH | 2020-12-24 | — | — | US | disclosed |
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | NATIONAL INSTITUTES OF HEALTH | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200399264-A1 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | MAVS, ZC3HAV1, EIF2AK2 | KDM4E 453/4885MAPT 347/4885CSNK2A2 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.